ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Coeptis Therapeutics Holdings, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 20.21%, its profits have fallen by -16.6%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Coeptis Therapeutics Holdings, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Coeptis Therapeutics Holdings, Inc.
17.66%
1.17
89.19%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.45%
EBIT Growth (5y)
-264.97%
EBIT to Interest (avg)
-4.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.82%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.55
EV to EBIT
-4.85
EV to EBITDA
-5.32
EV to Capital Employed
8.64
EV to Sales
64.10
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-178.24%
ROE (Latest)
-108.83%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
NET SALES(9M)
At USD 0.5 MM has Grown at inf%
NET PROFIT(HY)
Higher at USD -6.36 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -40.51 %
DEBTORS TURNOVER RATIO(HY)
Highest at 11.65 times
EPS(Q)
Highest at USD -0.58
-5What is not working for the Company
NET PROFIT(HY)
At USD -6.36 MM has Grown at -26.43%
RAW MATERIAL COST(Y)
Grown by 27,550% (YoY
Here's what is working for Coeptis Therapeutics Holdings, Inc.
Net Sales
At USD 0.5 MM has Grown at inf%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -6.36 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
EPS
Highest at USD -0.58
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -40.51 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 11.65 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Coeptis Therapeutics Holdings, Inc.
Net Profit
At USD -6.36 MM has Grown at -26.43%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Raw Material Cost
Grown by 27,550% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
